CaloSense Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
CaloSense General Information
Description
Developer of a remote patient monitoring platform designed to relieve pressure on healthcare providers. The company's platform is designed specifically for tracking patient weight and behaviors from smart connected devices with customizable alert triggers, enabling bariatric patients to independently manage their health.
Contact Information
Website
www.calosense.comCorporate Office
- 2 Beni Berman Street
- Netanya 4249330
- Israel
Corporate Office
- 2 Beni Berman Street
- Netanya 4249330
- Israel
CaloSense Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 01-Jan-2025 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Aug-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 05-Apr-2022 | $120K | $770K | Completed | Generating Revenue | |
| 1. Seed Round | 01-Mar-2022 | $650K | $650K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
CaloSense Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CaloSense Patents
CaloSense Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220296133-A1 | Methods circuits devices systems and machine executable code for glucose event detection | Inactive | 22-Mar-2021 | ||
| US-20210345915-A1 | Methods circuits devices systems and machine executable code for glucose monitoring analysis and remedy | Inactive | 09-May-2020 |
CaloSense Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CaloSense Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Techstars | Accelerator/Incubator | Minority | ||
| ARC Innovation Center of Sheba Medical Center | Corporation | Minority | ||
| BNP Paribas | Investment Bank | Minority | ||
| Dragones Venture Partners | Venture Capital | Minority | ||
| Sheba Medical Center | Corporation | Minority |
CaloSense FAQs
-
When was CaloSense founded?
CaloSense was founded in 2020.
-
Where is CaloSense headquartered?
CaloSense is headquartered in Netanya, Israel.
-
What is the size of CaloSense?
CaloSense has 11 total employees.
-
What industry is CaloSense in?
CaloSense’s primary industry is Other Healthcare Services.
-
Is CaloSense a private or public company?
CaloSense is a Private company.
-
What is CaloSense’s current revenue?
The current revenue for CaloSense is .
-
How much funding has CaloSense raised over time?
CaloSense has raised $770K.
-
Who are CaloSense’s investors?
Techstars, ARC Innovation Center of Sheba Medical Center, BNP Paribas, Dragones Venture Partners, and Sheba Medical Center have invested in CaloSense.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
